Health ❯ Obesity ❯ Weight Loss

Pharmaceuticals

GLP-1 Drugs Mounjaro Clinical Trials GLP-1 Receptor Agonists GLP-1 Agonists Drug Advertising Market Competition Experimental Drugs Eli Lilly Tirzepatide Injections NHS Trials Semaglutide Drug Pricing NHS Prescriptions Weight-Loss Injections Drug Approval Retatrutide GLP-1 Medications Orforglipron

Penn Study Finds About 30% Lower Breast Cancer Rates Associated With GLP‑1 Use

Confirming the association would reshape prevention and survivorship policy by testing causation, safety, cost, eligibility, duration

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

Key Treatment and Patient Traits Predict Weight Loss Success With GLP-1 Agonists